Oncgnostics GmbH

https://www.oncgnostics.com

Founded as a spin-off from the University Womens' Hospital Jena, oncgnostics focuses on in vitro diagnostic tests for the early and accurate detection of cancer utilizing proprietary epigenetic biomarkers. The diagnostic products will allow earlier detection of more cancer cases and thus contribute to the improvement of therapeutic success. The initial product developed, GynTect®, allows for the rapid and reliable detection of cervical precancerous lesions and cancer. Through strategic alliances with other industry leaders, oncgnostics aims to extend its reach around the world. *

	Start	2012-02-01 splitoff
	Predecessor	University of Jena (Friedrich-Schiller-Universität Jena)
	Industry	molecular diagnostics
	Industry 2	GynTect® test
	Person	Hansel, Alfred (Oncgnostics GmbH 201204 Managing Director + Co-founder)
	Person 2	Schmitz, Martina (Oncgnostics GmbH 201204 Managing Director + Co-founder)

	Region	Jena
	Country	Germany
	Street	41 Löbstedter Str.
	City	07749 Jena
	Tel	+49-3641-508456
		Address record changed: 2022-09-18

Basic data	Employees	A: 1 to 10 (2017-09-07)

		* Document for »About Section«:

		Record changed: 2023-12-30